Multi-omics discovery of exome-derived neoantigens in hepatocellular carcinoma

被引:0
|
作者
Markus W. Löffler
Christopher Mohr
Leon Bichmann
Lena Katharina Freudenmann
Mathias Walzer
Christopher M. Schroeder
Nico Trautwein
Franz J. Hilke
Raphael S. Zinser
Lena Mühlenbruch
Daniel J. Kowalewski
Heiko Schuster
Marc Sturm
Jakob Matthes
Olaf Riess
Stefan Czemmel
Sven Nahnsen
Ingmar Königsrainer
Karolin Thiel
Silvio Nadalin
Stefan Beckert
Hans Bösmüller
Falko Fend
Ana Velic
Boris Maček
Sebastian P. Haen
Luigi Buonaguro
Oliver Kohlbacher
Stefan Stevanović
Alfred Königsrainer
Hans-Georg Rammensee
机构
[1] University Hospital Tübingen,Department of General, Visceral and Transplant Surgery
[2] University of Tübingen,Interfaculty Institute for Cell Biology, Department of Immunology
[3] German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ) Partner Site Tübingen,Department of Clinical Pharmacology
[4] University Hospital Tübingen,Institute for Translational Bioinformatics
[5] University Hospital Tübingen,Quantitative Biology Center (QBiC)
[6] University of Tübingen,Center for Bioinformatics
[7] University of Tübingen,Department of Computer Science
[8] Applied Bioinformatics,Institute of Medical Genetics and Applied Genomics
[9] Present address: European Molecular Biology Laboratory,NGS Competence Center Tübingen (NCCT)
[10] European Bioinformatics Institute (EMBL-EBI),Present address: Department of General and Visceral Surgery
[11] University Hospital Tübingen,Institute of Pathology and Neuropathology
[12] Present address: Immatics Biotechnologies GmbH,Interfaculty Institute for Cell Biology, Proteome Center Tübingen (PCT)
[13] University of Tübingen,Internal Medicine, Department for Oncology, Hematology, Immunology, Rheumatology and Pulmonology
[14] Schwarzwald-Baar Hospital,Cancer Immunoregulation Unit
[15] University Hospital Tübingen,undefined
[16] University of Tübingen,undefined
[17] University of Tübingen,undefined
[18] Istituto Nazionale per lo Studio e la Cura dei Tumori,undefined
[19] “Fondazione Pascale” – IRCCS,undefined
[20] Max Planck Institute for Developmental Biology,undefined
[21] Biomolecular Interactions,undefined
来源
Genome Medicine | / 11卷
关键词
Hepatocellular carcinoma; HLA; HLA ligandomics; Immunoinformatics; Immunotherapy; Liver cancer; Mass spectrometry; Multi-omics; Neoantigen; Next-generation sequencing; Peptide prediction; Personalized medicine;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] Integrated multi-omics analysis of the clinical relevance and potential regulatory mechanisms of splicing factors in hepatocellular carcinoma
    Zhao, Yu-jia
    Wu, Lin-Yong
    Pang, Jin-shu
    Liao, Wei
    Chen, Yu-ji
    He, Yun
    Yang, Hong
    BIOENGINEERED, 2021, 12 (01) : 3978 - 3992
  • [22] PIWIL genes in hepatocellular carcinoma: a multi-omics approach uncovering dysregulated expression and ceRNA networks in mice
    Huang, Hailing
    Lu, Ruiqun
    Peng, Shenni
    Huang, Shi
    Mo, Yinyin
    Li, Genliang
    BMC GENOMIC DATA, 2024, 25 (01):
  • [23] Integrative analysis of multi-omics data identified PLG as key gene related to Anoikis resistance and immune phenotypes in hepatocellular carcinoma
    Wang, Xueyan
    Gao, Lei
    Li, Haiyuan
    Ma, Yanling
    Wang, Bofang
    Gu, Baohong
    Li, Xuemei
    Xiang, Lin
    Bai, Yuping
    Ma, Chenhui
    Chen, Hao
    JOURNAL OF TRANSLATIONAL MEDICINE, 2024, 22 (01)
  • [24] From 'Omics to Multi-omics Technologies: the Discovery of Novel Causal Mediators
    Mohammadi-Shemirani, Pedrum
    Sood, Tushar
    Pare, Guillaume
    CURRENT ATHEROSCLEROSIS REPORTS, 2023, 25 (02) : 55 - 65
  • [25] An individualized prognostic signature and multi-omics distinction for early stage hepatocellular carcinoma patients with surgical resection
    Ao, Lu
    Song, Xuekun
    Li, Xiangyu
    Tong, Mengsha
    Guo, You
    Li, Jing
    Li, Hongdong
    Cai, Hao
    Li, Mengyao
    Guan, Qingzhou
    Yan, Haidan
    Guo, Zheng
    ONCOTARGET, 2016, 7 (17) : 24097 - 24110
  • [26] Unraveling the TEC-associated landscape in hepatocellular carcinoma: a comprehensive study based on multi-omics analyses
    Jianwei Lan
    Longhui Xie
    Dekun Song
    Pengpeng Liu
    Quanyan Liu
    Discover Oncology, 16 (1)
  • [27] From ‘Omics to Multi-omics Technologies: the Discovery of Novel Causal Mediators
    Pedrum Mohammadi-Shemirani
    Tushar Sood
    Guillaume Paré
    Current Atherosclerosis Reports, 2023, 25 : 55 - 65
  • [28] Multi-Omics Profiling and Experimental Verification of Lysosomes-Related Genes in Hepatocellular Carcinoma
    Wang, Zhiyong
    Wang, Guoliang
    Zhao, Peng
    Sun, Ping
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2024, 28 (24)
  • [29] Comprehensive analysis of cell death genes in hepatocellular carcinoma based on multi-omics data
    Zhang, Lanlan
    Chen, Xiaomin
    Guo, Xiangchai
    Shen, Huajuan
    Qiu, Danying
    Jin, Weiqun
    Hou, Dongjie
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2023, 32 (02): : 233 - 244
  • [30] Applying multi-omics techniques to the discovery of biomarkers for acute aortic dissection
    Hao, Xinyu
    Cheng, Shuai
    Jiang, Bo
    Xin, Shijie
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9